You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer

Article metrics

Article menu

Download PDFPDF

XML
Clinical Trials Monitor
Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2025

AbstractFullPdf
Dec 2019330
Jan 202011111
Feb 2020252511
Mar 2020373717
Apr 2020212114
May 2020323215
Jun 2020191912
Jul 2020272717
Aug 20209972
Sep 2020292924
Oct 2020414072
Nov 2020222220
Dec 202013138
Jan 2021191921
Feb 2021212116
Mar 2021171719
Apr 2021222116
May 2021212119
Jun 2021212110
Jul 2021323222
Aug 2021121210
Sep 2021252517
Oct 2021262633
Nov 2021212130
Dec 2021394214
Jan 2022262712
Feb 2022212217
Mar 2022212112
Apr 2022363720
May 2022313121
Jun 2022626411
Jul 2022484815
Aug 2022343416
Sep 2022353618
Oct 2022273020
Nov 2022141415
Dec 2022242414
Jan 2023151516
Feb 2023515110
Mar 2023656524
Apr 2023151511
May 2023141411
Jun 202321218
Jul 202317178
Aug 202320229
Sep 2023282813
Oct 2023171714
Nov 202317179
Dec 2023333415
Jan 2024323212
Feb 2024323215
Mar 2024292926
Apr 2024393921
May 2024313223
Jun 2024282817
Jul 2024424213
Aug 202428259
Sep 2024202013
Oct 2024202015
Nov 2024484928
Dec 2024474823
Jan 2025464632
Feb 202511211338
Mar 2025494944
Apr 2025767769
May 2025232319
Jun 2025222218
Jul 2025110
Aug 2025110
Total198319981284